The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 3, 2008, Pages 246-249

  Gofrit, Ofer N ^a   Zorn, Kevin C ^a   Silvestre, Josephine ^a   Shalhav, Arieh L ^a   Zagaja, Gregory P ^a   Msezane, Lambda P ^a   Steinberg, Gary D ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Bladder cancer; Fluorescent in situ hybridization; Follow up; Recurrence

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CYSTOSCOPY; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; URINE CYTOLOGY;

DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; RECURRENCE; URINARY BLADDER NEOPLASMS;

EID: 42949128661     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.02.011     Document Type: Article

References (9)

1. Skacel M., Fahmy M., Brainard J.A., et al. Multi-target fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 169 (2003) 2101-2105
2. Halling K.C., King W., Sokolova I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164 (2000) 1768-1775
3. Bubendorf L., Grilli B., Sauter G., et al. Multi-probe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 116 (2001) 79-86
4. Sarosdy M.F., Schellhammer P., Bokinsky G., et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 168 (2002) 1950-1954
5. Friedrich M.G., Toma M.I., Hellstern A., et al. Comparison of multi-target fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer. BJU Int 91 (2003) 911-914
6. Zellweger T., Benz G., Cathomas G., et al. Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer 119 (2006) 1660-1665
7. American Joint Committee on Cancer. Urinary bladder. AJCC Cancer Staging Manual. 6th ed. (2002), Springer, New York 335-340
8. Soloway M.S., Bruck D.S., and Kim S.S. Expectant management of small, recurrent, noninvasive papillary bladder tumors. J Urol 170 (2003) 438-441
9. Gofrit O.N., Pode D., Lazar A., et al. Watchful waiting policy in recurrent Ta G1 bladder tumor. Eur Urol 49 (2006) 303-306